Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.

We examined the expression level of several genes that regulate distinct steps of metastasis in formalin-fixed, paraffin-embedded, archival specimens of primary human pancreatic carcinomas from patients undergoing curative surgery. The expression of epidermal growth factor receptor, E-cadherin, type IV collagenase [matrix metalloproteinase (MMP) 2 and MMP-9), basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and interleukin 8 was examined by a colorimetric in situ mRNA hybridization technique. Down-regulation of E-cadherin and up-regulation of type IV collagenase (MMP-9 and MMP-2) at the periphery of the neoplasms (P = 0.0167, 0.0102, and 0.0349, respectively) had significant prognostic value. The ratio of type IV collagenase expression (mean of the expression of MMP-2 and MMP-9) to E-cadherin expression (MMP:E-cadherin ratio) at the periphery of the tumors was significantly higher in patients with recurrent disease (4.7 +/- 2.1) than in patients who were disease free (2.3 +/- 1.7; P = 0.0008). Death from pancreatic cancer was significantly associated with a high MMP:E-cadherin ratio (>3.0) by overall survival analysis (P < 0.0002), whereas a low MMP:E-cadherin ratio (<3.0) was found in seven of eight patients alive 28-64 months after surgery. Multivariate analysis of overall survival showed that the MMP:E-cadherin ratio was a significant independent prognostic factor, whereas stage, nodal metastasis, and histological type were not. These data show that multiparametric analysis for several metastasis-related genes may allow physicians to assess the metastatic potential and hence predict the clinical outcome of individual patients with resectable pancreatic carcinoma.

[1]  A. Kugler.  Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.

[2]  T. Breslin,et al.  Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. , 1998, Frontiers in bioscience : a journal and virtual library.

[3]  G. Klöppel,et al.  Tumors of the Pancreas , 1997 .

[4]  C. Bucana,et al.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.

[5]  Jeffrey E. Lee,et al.  Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Leach,et al.  bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  L. Ellis,et al.  Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. , 1996, The American journal of pathology.

[8]  C. Bucana,et al.  Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. , 1996, Differentiation; research in biological diversity.

[9]  A. Piccoli,et al.  Survival after resection for ductal adenocarcinoma of the pancreas , 1996, The British journal of surgery.

[10]  D. Klimstra,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.

[11]  T. Nagakawa,et al.  Results of extensive surgery for pancreatic carcinoma , 1996, Cancer.

[12]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[13]  J. Abbruzzese,et al.  Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. , 1995, American journal of surgery.

[14]  Jeffrey E. Lee,et al.  Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head* , 1996 .

[15]  S. Matsuno,et al.  Usefulness of Japanese staging in the prognosis of patients treated operatively for adenocarcinoma of the head of the pancreas. , 1996, Journal of the American College of Surgeons.

[16]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis. , 1995, The American surgeon.

[17]  L. Ellis,et al.  Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  S. Kern,et al.  Molecular genetics of exocrine pancreatic neoplasms. , 1995, The Surgical clinics of North America.

[19]  W. Strodel,et al.  Expression of p53 protein in pancreatic adenocarcinoma , 1995 .

[20]  T. Colby,et al.  Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving? , 1995, Annals of surgery.

[21]  S. Ishihara,et al.  Expression of e-cadherin, alpha-catenins and Beta-catenins in human gastric carcinomas - correlation with histology and tumor progression. , 1995, Oncology reports.

[22]  L. Ellis,et al.  In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. , 1995, The American journal of pathology.

[23]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[24]  R. Hruban,et al.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.

[25]  C. Bucana,et al.  Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. , 1994, The American journal of pathology.

[26]  C. Bucana,et al.  Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. , 1994, Cancer research.

[27]  W. Yasui,et al.  [Molecular diagnosis on gastrointestinal cancers]. , 1994, Rinsho byori. The Japanese journal of clinical pathology.

[28]  N. Pellegata,et al.  K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. , 1994, Cancer research.

[29]  Y. Doki,et al.  E-Cadherin and α-Catenin Expression in Human Esophageal Cancer , 1994 .

[30]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[31]  D. Ruiter,et al.  E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome , 1993, International journal of cancer.

[32]  G. Brabant,et al.  E-cadherin: a differentiation marker in thyroid malignancies. , 1993, Cancer research.

[33]  Toshiya Takeda,et al.  An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging , 1993, Cancer.

[34]  S. Goodman,et al.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.

[35]  A. Umezawa,et al.  Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer , 1993, Journal of surgical oncology.

[36]  T. Nagakawa,et al.  Perineural invasion of carcinoma of the pancreas and biliary tract , 1993, The British journal of surgery.

[37]  C. Bucana,et al.  A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  M. Quintanilla,et al.  Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. , 1993, The American journal of pathology.

[39]  W. Birchmeier,et al.  E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. , 1993, Cancer research.

[40]  R. Poulsom,et al.  E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.

[41]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[42]  L. Ellis,et al.  A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. , 1993, Cancer research.

[43]  D. V. van Thiel,et al.  The 11 ‐year pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981‐1991 , 1993, Journal of surgical oncology. Supplement.

[44]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[45]  D. Brigati,et al.  Complete one-hour immunocytochemistry based on capillary action. , 1992, BioTechniques.

[46]  D. Brigati,et al.  Automated Molecular Pathology : One Hour In Situ DNA Hybridization , 1991 .

[47]  W. Birchmeier,et al.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. , 1991, Cancer research.

[48]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[49]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[50]  L. Liotta,et al.  Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.

[51]  H. Shimada,et al.  Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. , 1991, Cancer research.

[52]  Y Shimoyama,et al.  Expression of E- and P-cadherin in gastric carcinomas. , 1991, Cancer research.

[53]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[54]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[55]  L. Liotta,et al.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[56]  S. Shapiro,et al.  Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. , 1991, Journal of immunology.

[57]  J. Cameron,et al.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. , 1991, American journal of surgery.

[58]  A. Eisen,et al.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.

[59]  L. Matrisian,et al.  Stromelysin/transin and tumor progression. , 1990, Seminars in cancer biology.

[60]  L. Liotta,et al.  Metalloproteinases and cancer invasion. , 1990, Seminars in cancer biology.

[61]  I. Fidler,et al.  Genetic control of cancer metastasis. , 1990, Journal of the National Cancer Institute.

[62]  M. Takeichi,et al.  Cadherins: a molecular family important in selective cell-cell adhesion. , 1990, Annual review of biochemistry.

[63]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[64]  S. Hirohashi,et al.  Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.

[65]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[66]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[67]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[68]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[69]  M. Takeichi,et al.  The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. , 1988, Development.

[70]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Weinberg,et al.  Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.

[72]  A. Moossa,et al.  Survival in 1001 patients with carcinoma of the pancreas. , 1987, Annals of surgery.

[73]  H. Strander.  Interferon treatment of human neoplasia. , 1986, Advances in cancer research.

[74]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[75]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[76]  M. Caruthers,et al.  Chemical synthesis and biological studies on mutated gene-control regions. , 1983, Cold Spring Harbor Symposia on Quantitative Biology.

[77]  T. Allen‐Mersh.  Significance of the site of origin of pancreatic exocrine adenocarcinoma. , 1982, Journal of clinical pathology.

[78]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[79]  N. Breslow,et al.  396: Remarks on the Conservatism of Σ(0 - E) 2 /E in Survival Data , 1975 .

[80]  N. Breslow,et al.  Remarks on the conservatism of sigma(0 -- E)2/E in survival data. , 1975, Biometrics.

[81]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[82]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.

[83]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[84]  D.,et al.  Regression Models and Life-Tables , 2022 .